Cite

HARVARD Citation

    Dodick, D. et al. (2020). Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment. Cephalalgia. pp. 935-948. [Online]. 
  
Back to record